Management and board


Sara Thorslund, PhD (b 1977)
– CEO since 2009 –
Co-founder of Gradientech. Solid background within MEMS fabrication and diagnostic POC applications for microfluidics. Sara Thorslund holds a PhD in Material Science.

Ann-Sofie Andersson (b 1964)
– Sales & Marketing Manager since 2013 –
More than 25 years of experience from research, sales and marketing within diagnostics, pharmaceutical and biotech companies like Pharmacia and Mercodia.

Board of Directors

Gisela Sitbon, PhD (b 1958)
– Chairman since 2020 –
Gisela has a research background within molecular biology, combined with more than 25 years of senior level experience from the life science industry. This includes business development and operational positions, as well as co-founding and managing a service-providing diagnostic company, later acquired by Capio. Gisela currently holds several chair positions and board appointments in private and stock market listed companies.

Ted Elvhage (b 1968)
– Director since 2014 –
Business administration and biochemistry background with leading sales positions at IT companies and life science companies like Pall. Founding partner of several business angel networks, engagements in numerous start-ups and Investmentpodden. Other current commitments include position as chairman for Keiretsu Forum Nordics, and board member of Fingerprint Cards.

Karl Xavier (b 1978)
– Director since 2017 –
Background as financial advisor and investment management for high net-worth and corporate clients. Investment manager for Venture Capital firms and well experienced in evaluating and building early stage companies. Board member of several start-up companies.

Henrik Didner, PhD (b 1958)
– Director since 2018 –
Co-founder, owner and working chairman of the Swedish leading fund management firm Didner&Gerge. Other commitments include the position as chairman for Uppsala University Holding. Henrik Didner holds a PhD in Business Administration.

Rolf Ehrnström (b 1953)
– Director since 2020 –
Rolf has extensive R&D leadership experience from biotech and diagnostic companies like Amersham Pharmacia Biotech, Dako (acquired by Agilent) and the microfluidics pioneer company Gyros. Rolf Ehrnström is today CSO of the stock market listed diagnostics company Immunovia, board member of Scandinavian Chemotech AB and appointed independent partner at Ventac Partners.

Simon Turner (b 1988)
– Director since 2020 –
Simon has a background as an investment analyst, with focus on diagnostics, medtech and digital solutions. Simon Turner has solid experience from international due diligence work at French Kurma Partners, and later as Senior Manager Innovation Scout at Baxter International.

Scientific Advisory Board

Jeffrey Bender, MD Assoc. Prof Clinical Pediatrics
Jeffrey is an Infection Disease Physician, Medical Microbiologist and Associate Professor of Clinical Pediatrics at Children’s Hospital Los Angeles, CA, USA. His research is centered on understanding the role of the infant’s microbiome and its host interactions. Jeffrey is also interested in hospital epidemiology and the implementation of rapid diagnostics in the pediatric setting.

Øyvind Kommedal, MD PhD
Consultant in medical microbiology at Haukeland University, Bergen, Norway. In his research he focuses on culture independent detection of bacteria and poly-microbial infections. Working in a diagnostic lab, he has a keen interest in technologies that can reduce time to result for patient specimens.

Mia Phillipson, PhD Prof Physiology
The laboratory of Mia Phillipson at the Dept of Medical Cell Biology at Uppsala University, Sweden, is focusing on defining the role and function of immune cells in inflammation, as well as during angiogenesis and maintenance of homeostasis. Mia Phillipson was appointed Ragnar Söderberg Research Fellow in medicine, 2012 and Wallenberg Academy Fellow, 2012.

Jonas Bergquist, MD PhD Prof Analytical Chemistry and Neuro Chemistry
Background as MD and Associate Professor in Clinical Neuroscience from Sahlgrenska University Hospital in Gothenburgh, Sweden. Since 2005 having a position as professor at the Department of Chemistry at Uppsala University, Sweden, with reserach focused on neuro degenerative diseases like ALS and MS. Since 2011 also Adjunct Prof at University of Utah, Salt Lake City, USA.